Skip Navigation LinksHome > November 2008 - Volume 50 - Issue 11 > The Direct and Indirect Cost Burden of Crohn's Disease and U...
Journal of Occupational & Environmental Medicine:
doi: 10.1097/JOM.0b013e318181b8ca
Original Articles

The Direct and Indirect Cost Burden of Crohn's Disease and Ulcerative Colitis

Gibson, Teresa B. PhD; Ng, Eliza MD; Ozminkowski, Ronald J. PhD; Wang, Shaohung PhD; Burton, Wayne N. MD; Goetzel, Ron Z. PhD; Maclean, Ross MD, MBA

Collapse Box


Objective: To estimate the direct medical and indirect (absenteeism and short-term disability) cost burden of Crohn's Disease (CD) and Ulcerative Colitis (UC).

Methods: Data were obtained from 1999 to 2005 MarketScan databases. Twelve-month expenditures for patients with CD and UC were compared to expenditures among an equal number of propensity score matched comparison group patients. Regression analysis controlled for demographics and case-mix.

Results: Annual medical expenditures were significantly higher for commercially insured CD and UC patients compared to matched comparison group patients ($18,963 vs $5300 for CD patients, $15,020 vs $4982 for UC patients, respectively, all P < 0.001). Indirect costs were also high for employed patients with these conditions.

Conclusions: CD and UC are costly diseases with a significant cost burden related to health care utilization and productivity loss.

©2008The American College of Occupational and Environmental Medicine


Article Tools


Article Level Metrics